432 related articles for article (PubMed ID: 37460828)
21. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
22. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
[TBL] [Abstract][Full Text] [Related]
23. Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
Zhu R; Jalo E; Silvestre MP; Poppitt SD; Handjieva-Darlenska T; Handjiev S; Huttunen-Lenz M; Mackintosh K; Stratton G; Navas-Carretero S; Pietiläinen KH; Simpson E; Macdonald IA; Muirhead R; Brand-Miller J; Fogelholm M; Færch K; Martinez JA; Westerterp-Plantenga MS; Adam TC; Raben A
Diabetes Care; 2022 Nov; 45(11):2698-2708. PubMed ID: 35696263
[TBL] [Abstract][Full Text] [Related]
24. Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance.
Osei E; Zandbergen A; Brouwers PJAM; Mulder LJMM; Koudstaal P; Lingsma H; Dippel DWJ; den Hertog H
BMJ Open; 2021 Sep; 11(9):e046113. PubMed ID: 34531203
[TBL] [Abstract][Full Text] [Related]
25. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.
Panigrahi A; Mohanty S
BMC Endocr Disord; 2023 Sep; 23(1):190. PubMed ID: 37679692
[TBL] [Abstract][Full Text] [Related]
28. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Koivula RW; Forgie IM; Kurbasic A; Viñuela A; Heggie A; Giordano GN; Hansen TH; Hudson M; Koopman ADM; Rutters F; Siloaho M; Allin KH; Brage S; Brorsson CA; Dawed AY; De Masi F; Groves CJ; Kokkola T; Mahajan A; Perry MH; Rauh SP; Ridderstråle M; Teare HJA; Thomas EL; Tura A; Vestergaard H; White T; Adamski J; Bell JD; Beulens JW; Brunak S; Dermitzakis ET; Froguel P; Frost G; Gupta R; Hansen T; Hattersley A; Jablonka B; Kaye J; Laakso M; McDonald TJ; Pedersen O; Schwenk JM; Pavo I; Mari A; McCarthy MI; Ruetten H; Walker M; Pearson E; Franks PW;
Diabetologia; 2019 Sep; 62(9):1601-1615. PubMed ID: 31203377
[TBL] [Abstract][Full Text] [Related]
29. Impact of a comprehensive digital health programme on HbA
McLeod M; Stanley J; Signal V; Stairmand J; Thompson D; Henderson K; Davies C; Krebs J; Dowell A; Grainger R; Sarfati D
Diabetologia; 2020 Dec; 63(12):2559-2570. PubMed ID: 32886192
[TBL] [Abstract][Full Text] [Related]
30. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
Gerstein HC; Coleman RL; Scott CAB; Xu S; Tuomilehto J; Rydén L; Holman RR;
Diabetes Care; 2020 Sep; 43(9):2242-2247. PubMed ID: 32641379
[TBL] [Abstract][Full Text] [Related]
31. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
Rissanen A; Howard CP; Botha J; Thuren T;
Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
[TBL] [Abstract][Full Text] [Related]
32. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
van den Burg EL; Schoonakker MP; van Peet PG; van den Akker-van Marle EM; Lamb HJ; Longo VD; Numans ME; Pijl H
Diabetologia; 2024 Jul; 67(7):1245-1259. PubMed ID: 38546821
[TBL] [Abstract][Full Text] [Related]
33. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock J; Frias J; Jastreboff AM; Du Y; Lou J; Gurbuz S; Thomas MK; Hartman ML; Haupt A; Milicevic Z; Coskun T
Lancet; 2023 Aug; 402(10401):529-544. PubMed ID: 37385280
[TBL] [Abstract][Full Text] [Related]
34. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
[TBL] [Abstract][Full Text] [Related]
35. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
38. Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study.
PrayGod G; Changalucha J; Kapiga S; Peck R; Todd J; Filteau S
BMC Infect Dis; 2017 Jan; 17(1):103. PubMed ID: 28137307
[TBL] [Abstract][Full Text] [Related]
39. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
[TBL] [Abstract][Full Text] [Related]
40. Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania.
Nkinda L; Buberwa E; Memiah P; Ntagalinda A; George M; Msafiri F; Joachim A; Majigo M; Ramaiya K; Sunguya B
Front Endocrinol (Lausanne); 2022; 13():1045628. PubMed ID: 36561566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
